Prestige BioPharma Limited (KRX:950210)
South Korea
· Delayed Price · Currency is KRW 13,670
+290 (2.17%)
At close: Dec 5, 2025
-8.26% (1Y)
| Market Cap | 164.30B |
| Revenue (ttm) | 14.41B |
| Net Income (ttm) | 15.76B |
| Shares Out | 12.02M |
| EPS (ttm) | 262.37 |
| PE Ratio | 52.10 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 143,720 |
| Average Volume | 131,928 |
| Open | 13,570 |
| Previous Close | 13,380 |
| Day's Range | 13,380 - 13,990 |
| 52-Week Range | 11,000 - 20,000 |
| Beta | 0.98 |
| RSI | 64.24 |
| Earnings Date | Feb 27, 2026 |